Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RBL 001/RBL 002

Next Previous
Drug Profile

RBL 001/RBL 002

Alternative Names: MERIT; RB0001; RB_0001; RBL-001/RBL-002; RBL-002/RBL-001

Latest Information Update: 04 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BioNTech; Ribological
  • Developer Ribological
  • Class Cancer vaccines; RNA vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Malignant melanoma

Most Recent Events

  • 28 Jan 2020 No recent reports of development identified for phase-I development in Malignant-melanoma in Austria (Intralymphatic, Injection)
  • 28 Jan 2020 No recent reports of development identified for phase-I development in Malignant-melanoma in Germany (Intralymphatic, Injection)
  • 01 Oct 2019 BioNtech completes a phase I trial for Malignant melanoma (Late-stage disease) in Germany and Austria (NCT02035956)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top